Trials / Recruiting
RecruitingNCT06780267
Clinical Study of HRS-2129 for Postoperative Analgesia in Orthopaedics
Clinical Study on Safety and Efficacy of HRS-2129 for Postoperative Analgesiain Orthopaedics
- Status
- Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 195 (estimated)
- Sponsor
- Shandong Suncadia Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The study is being conducted to evaluate the safety, and efficacy of HRS-2129 for Postoperative analgesia in orthopaedics. To explore the reasonable dosage of HRS-2129 for Postoperative analgesia in orthopaedics.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-2129 | HRS-2129 |
| DRUG | HRS-2129 placebo | HRS-2129 placebo |
| DRUG | Tramadol Hydrochloride SR Tablets | Tramadol Hydrochloride SR Tablets |
Timeline
- Start date
- 2025-03-11
- Primary completion
- 2026-01-01
- Completion
- 2026-02-01
- First posted
- 2025-01-17
- Last updated
- 2025-11-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06780267. Inclusion in this directory is not an endorsement.